ARGENX SE is 72.0x more valuable than Cullinan Therapeutics, Inc. by market capitalization ($53.35 B vs $740.57 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CGEM | ARGX |
|---|---|---|
| Market cap | $740.57 M | $53.35 B |
| US-listed rank | #2664 | #306 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$219.88M | - |
| SEC filings | 435 | 272 |
ARGENX SE is 72.0x more valuable than Cullinan Therapeutics, Inc. by market capitalization ($53.35 B vs $740.57 M).
Full pages: Cullinan Therapeutics, Inc. and ARGENX SE, or browse the full rankings.